1. Home
  2. CNXC vs ARDX Comparison

CNXC vs ARDX Comparison

Compare CNXC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concentrix Corporation

CNXC

Concentrix Corporation

HOLD

Current Price

$22.26

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.04

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXC
ARDX
Founded
1991
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
CNXC
ARDX
Price
$22.26
$5.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$54.80
$15.14
AVG Volume (30 Days)
1.9M
3.5M
Earning Date
03-24-2026
04-30-2026
Dividend Yield
5.79%
N/A
EPS Growth
N/A
N/A
EPS
1.20
N/A
Revenue
$9,825,771,000.00
$2,607,000.00
Revenue This Year
$5.29
$37.75
Revenue Next Year
$2.49
$34.24
P/E Ratio
$18.54
N/A
Revenue Growth
2.15
N/A
52 Week Low
$19.12
$4.08
52 Week High
$59.92
$8.40

Technical Indicators

Market Signals
Indicator
CNXC
ARDX
Relative Strength Index (RSI) 43.78 36.58
Support Level $22.05 $4.95
Resistance Level $25.93 $5.34
Average True Range (ATR) 1.58 0.19
MACD -0.02 0.00
Stochastic Oscillator 36.68 9.49

Price Performance

Historical Comparison
CNXC
ARDX

About CNXC Concentrix Corporation

Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: